1. Home
  2. FSI vs GANX Comparison

FSI vs GANX Comparison

Compare FSI & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

HOLD

Current Price

$5.50

Market Cap

63.7M

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.91

Market Cap

88.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSI
GANX
Founded
1991
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.7M
88.6M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
FSI
GANX
Price
$5.50
$1.91
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
22.3K
473.3K
Earning Date
04-15-2026
05-13-2026
Dividend Yield
1.53%
N/A
EPS Growth
N/A
31.46
EPS
N/A
N/A
Revenue
$15,494,325.00
$55,180.00
Revenue This Year
$63.39
N/A
Revenue Next Year
$43.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.85
$1.53
52 Week High
$11.48
$4.34

Technical Indicators

Market Signals
Indicator
FSI
GANX
Relative Strength Index (RSI) 49.77 57.60
Support Level $5.24 $1.64
Resistance Level $5.52 $2.05
Average True Range (ATR) 0.20 0.12
MACD 0.07 0.00
Stochastic Oscillator 63.83 48.44

Price Performance

Historical Comparison
FSI
GANX

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The company also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: